BOTANIX PHARMACEUTICALS LTD — Share Issue/Capital Change 2023

May 17, 2023

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

BOTANIX PHARMACEUTICALS LTD

Announcement Type

New announcement

Date of this announcement

Thursday May 18, 2023

The +securities to be quoted are:

+Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
BOT	ORDINARY FULLY PAID	6,166,667	18/05/2023

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

BOTANIX PHARMACEUTICALS LTD

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ABN

Registration number 70009109755

1.3 ASX issuer code

BOT

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

18/5/2023

Application for quotation of +securities

2 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued under an +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer

2.2 The +securities to be quoted are:

==> picture [8 x 8] intentionally omitted <==

Additional +securities in a class that is already quoted on ASX ("existing class")

Application for quotation of +securities

3 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Additional +securities to be quoted in an existing class issued under an +employee incentive scheme

FROM (Existing Class) ASX +security code and description BOTAAD : PERFORMANCE RIGHTS

TO (Existing Class) ASX +security code and description BOT : ORDINARY FULLY PAID

Please state the number of +securities issued under the +employee incentive scheme that are not subject to a restriction on transfer or that are to be quoted notwithstanding there is a restriction on transfer 6,166,667

Please provide details of a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

Refer https://announcements.asx.com.au/asxpdf/20221021/pdf/45gkp0s2trhxds.pdf

Are any of these +securities being issued to +key management personnel (KMP) or an +associate Yes

Provide details of the KMP or +associates being issued +securities

Name of KMP	Name of registered holder	Number of +securities
Vince Ippolito	Vince Ippolito	2,000,000
Matthew Callahan	Shenasaby Pty Ltd	1,666,667
William Bosch	William Bosch	500,000
Howard McKibbon	Howard McKibbon	2,000,000

Issue date

18/5/2023

Application for quotation of +securities

4 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

==> picture [9 x 8] intentionally omitted <==

Yes

Issue details

Number of +securities to be quoted

6,166,667

Are the +securities being issued for a cash consideration?

==> picture [9 x 8] intentionally omitted <==

No

Please describe the consideration being provided for the +securities

Conversion of vested performance rights into shares.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

0.000000

Any other information the entity wishes to provide about the +securities to be quoted Conversion of 6,166,667 vested performance rights into 6,166,667 shares.

Application for quotation of +securities

5 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

	Total number of
ASX +security code and description	+securities on issue
BOT : ORDINARY FULLY PAID	1,311,784,619

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
BOTAAD : PERFORMANCE RIGHTS	6,833,335
BOTAD : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	82,787,518
BOTAAC : OPTION EXPIRING 14-APR-2025 EX $0.072	10,000,000
BOTAAB : OPTION EXPIRING 22-MAR-2025 EX $0.094	4,000,000
BOTAAE : OPTION EXPIRING 13-MAR-2026 EX $0.078	8,500,000
BOTAF : OPTION EXPIRING 7-OCT-2024 EX $0.089	10,000,000

Application for quotation of +securities

6 / 7

Application for quotation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

9

Application for quotation of +securities

7 / 7